CClinicalTrials.gg
RecruitingNCT07865338Updated Oct 8, 2026

Patterns of Rehabilitation After Spinal Cord Injury

An observational study in Spinal Cord Injury, sponsored by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-08.

Sponsored by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital · Observational

Updated Oct 8, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
103
Ages
18 Years and older
Sex
All
01

Study summary

Patients with spinal cord injuries typically achieve a level of independence that allows them to return to their daily lives through an acute-phase rehabilitation program. However, in our country, it has been observed that many patients continue to make multiple hospital visits for rehabilitation purposes even in the later stages following a spinal cord injury, resulting in prolonged hospital stays. This situation negatively affects both the patients' social lives and their financial situations. Additionally, it places a burden on rehabilitation centers.

The aim of this study is to examine the length of hospital stays and the time it takes for patients to return to their daily lives as they continue rehabilitation following a spinal cord injury.

02

Conditions studied

  • Spinal Cord Injury
03

In context

Spinal Cord Injuries

1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.

This study's planned enrollment of 103 is above the median of 60 across 323 observational studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

Gaziler Physical Medicine and Rehabilitation Education and Research Hospital is the lead sponsor of 81 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Be under follow-up for a spinal cord injury

Inclusion criteria

  • Be under follow-up for a spinal cord injury
  • Be 18 years of age or older

Exclusion criteria

Exclusion Criteria:

  • Presence of a neurological condition other than a spinal cord injury
  • Presence of a psychiatric condition
  • Cognitive impairment that impairs communication
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
103 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. The patient's hospital stays for rehabilitation purposes, as well as the number of centers they visited

    Time frame: at hospital admission

Secondary outcomes

  1. how many months after his injury he began the rehabilitation program

    Time frame: at hospital admission

07

Study locations

1 of 1 sites recruiting
  • Gaziler Physical Therapy and Rehabilitation Training and Research Hospital
    Ankara, Çankaya 06800, Turkey (Türkiye)
    Recruiting
08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 8, 2026
Show all 1 update
  1. Oct 8, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07865338
Lead sponsor
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Responsible party
Ayse Naz Kalem (PM&R Specialist, Gaziler Physical Medicine and Rehabilitation Education and Research Hospital) — Principal investigator
First posted
Oct 8, 2026
Start date
Oct 6, 2026 (estimated)
Primary completion
Mar 30, 2027 (estimated)
Completion
Mar 30, 2027 (estimated)
Last update
Oct 8, 2026

Study contacts

Arzum Palas, Resident
Contact
arzumpalas@gmail.com
+90 0312 291 10 00

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion